Emergent Biosolutions's total assets for Q4 2025 were $1.32B, a decrease of -9.75% from the previous quarter. EBS total liabilities were $796.00M for the fiscal quarter, a -9.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.